Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|16|2432-2439

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.16, 2014-08, pp. : 2432-2439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of early‐stage prostate cancer among rural and urban patients

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3067-3075

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variation in treatment associated with life expectancy in a population‐based cohort of men with early‐stage prostate cancer

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3642-3650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early‐stage prostate cancer

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3446-3453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overtreatment of men with early‐stage prostate cancer and limited life expectancy

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3592-3594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expectant management for men with early stage prostate cancer

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 4, 2015-07 ,pp. : 264-282

John Wiley & Sons Inc

Access to resources Recommend Favorite